Clinical Trial To Test Mosquito Saliva Vaccine For Malaria, Zika And Dengue Viruses A Phase 1 clinical trial of an experimental vaccine designed to provide protection against mosquito-borne diseases such as malaria, Zika and dengue will involve up to 60 adult participants. How does this AGS-v vaccine work? by Allan Adamson